Marie Frutoso

Dr. Marie Frutoso

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in Nature
Verified
Journal Article
Open access
PDF file
FMFlorian Mair
Florian Mair
JEJami R. Erickson
Jami R. Erickson
MFMarie Frutoso
Marie Frutoso
AKAndrew J. Konecny
Andrew J. Konecny
EGEvan Greene
Evan Greene
MPMartin Prlic
Martin Prlic
Immunotherapies have achieved remarkable successes in the treatment of cancer, but major challenges remain1,2. An inherent weakness of current treatment approaches is that therapeutically targeted pathways are not restricted to tumours, but are also found in other tissue microenvironments, complicating treatment3,4. Despite great efforts to define inflammatory processes in the tumour microenvironment, the understanding of tumour-unique immune alterations is limited by a knowledge gap regarding the immune cell populations in inflamed human tissues. Here, in an effort to identify such tumour-enriched immune alterations, we used complementary single-cell analysis approaches to interrogate the immune infiltrate in human head and neck squamous cell carcinomas and site-matched non-malignant, inflamed tissues. Our analysis revealed a large overlap in the composition and phenotype of immune cells in tumour and inflamed tissues. Computational analysis identified tumour-enriched immune cell interactions, one of which yields a large population of regulatory T (Treg) cells that is highly enriched in the tumour and uniquely identified among all haematopoietically-derived cells in blood and tissue by co-expression of ICOS and IL-1 receptor type 1 (IL1R1). We provide evidence that these intratumoural IL1R1+ Treg cells had responded to antigen recently and demonstrate that they are clonally expanded with superior suppressive function compared with IL1R1− Treg cells. In addition to identifying extensive immunological congruence between inflamed tissues and tumours as well as tumour-specific changes with direct disease relevance, our work also provides a blueprint for extricating disease-specific changes from general inflammation-associated patterns.

12 November 2021 in Science Advances
Verified
Journal Article
Open access
SVSarah C. Vick
Sarah C. Vick
MFMarie Frutoso
Marie Frutoso
FMFlorian Mair
Florian Mair
AKAndrew J. Konecny
Andrew J. Konecny
EGEvan Greene
Evan Greene
JLJennifer M. Lund
Jennifer M. Lund
Unique circulating regulatory T cell phenotypes distinguish hospitalized patients with SARS-CoV-2.

26 September 2020 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
MFMarie Frutoso
Marie Frutoso
FMFlorian Mair
Florian Mair
MPMartin Prlic
Martin Prlic
Purpose and appropriate samples: This 27‐color panel has been validated and optimized to comprehensively profile natural killer (NK) cells isolated from human tumors using a collagenase Type II‐based digestion protocol. We confirmed that detection of protein expression by antibodies used in our final panel was not affected during tissue digestion. During this evaluation process, we found that detection of CD56, a biomarker typically used to identify NK cells, was affected substantially by collagenase‐based digestion. Thus, our panel is centered around expression of NKp46, which is sufficient to identify NK cells and not affected by the tissue collagenase digestion step. Our panel further includes biomarkers used to extrapolate NK‐cell maturation, differentiation, migration, homing potential, and functional state. Our panel is intended to provide in‐depth characterization of human NK cells isolated from tissues, which we specifically tested using oral squamous cell carcinomas tissues, but it is compatible with other tissues that can be dissociated with a collagenase Type II‐based protocol. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.

Verified
Journal Article
Open access
PDF file
MFMarie Frutoso
Marie Frutoso
EMErwan Mortier
Erwan Mortier
Natural Killer (NK) cells are a type of cytotoxic lymphocytes that play an important role in the innate immune system. They are of particular interest for their role in elimination of intracellular pathogens, viral infection and tumor cells. As such, numerous strategies are being investigated in order to potentiate their functions. One of these techniques aims at promoting the function of their activating receptors. However, different observations have revealed that providing activation signals could actually be counterproductive and lead to NK cells’ hyporesponsiveness. This phenomenon can occur during the NK cell education process, under pathological conditions, but also after treatment with different agents, including cytokines, that are promising tools to boost NK cell function. In this review, we aim to highlight the different circumstances where NK cells become hyporesponsive and the methods that could be used to restore their functionality.

15 July 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MFMarie Frutoso
Marie Frutoso
SMSébastien Morisseau
Sébastien Morisseau
FTFella Tamzalit
Fella Tamzalit
AQAgnès Quéméner
Agnès Quéméner
DMDihia Meghnem
Dihia Meghnem
EMErwan Mortier
Erwan Mortier
IL-15 is a cytokine playing a crucial role in the function of immune cells, including NK and CD8 T cells. In this study, we demonstrated that in vivo, in mice, IL-15–prestimulated NK cells were no longer able to respond to a second cycle of IL-15 stimulation. This was illustrated by defects in cell maturation, proliferation, and activation, seemingly linked to the environment surrounding NK cells but not related to the presence of CD4 regulatory T cells, TGF-β, or IL-10. Moreover, NK cells from immunodeficient mice could respond to two cycles of IL-15 stimulation, whereas an adoptive transfer of CD44+CD8+ cells impaired their responsiveness to the second cycle. Conversely, in immunocompetent mice, NK cell responsiveness to a second IL-15 stimulation was restored by the depletion of CD8+ cells. These biological findings refine our understanding of the complex mode of action of NK cells in vivo, and they should be taken into consideration for IL-15–based therapy.

5 December 2019 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
AQAgnès Quéméner
Agnès Quéméner
SMSébastien Morisseau
Sébastien Morisseau
RSRui P Sousa
Rui P Sousa
KTKilian Trillet
Kilian Trillet
MMMike Maillasson
Mike Maillasson
EMErwan Mortier
Erwan Mortier
Interleukin(IL)-15 plays an important role in the communication between immune cells. IL-15 delivers its signal through different modes involving three receptor chains: IL-15Rα, IL-2Rβ and γc. The combination of the different chains result in the formation of IL-15Rα/IL-2Rβ/γc trimeric or IL-2Rβ/γc dimeric receptors. In this study, we aimed at investigating the role of IL-15Rα chain in stabilizing the cytokine in the IL-2Rβ/γc dimeric receptor. By analyzing the key residues of IL-15 facing IL-2Rβ, we provided evidence of differential interfaces in the presence or in the absence of membrane-anchored IL-15Rα. Moreover, we found that the anchorage of IL-15Rα to the cell surface regardless its mode of presentation, in cis or in trans, is crucial for complete signaling. These observations show how the cells can finely modulate the intensity of cytokine signaling through the quality and the level of expression of the receptor chains.